These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21480981)

  • 1. Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement.
    Belaidi E; Beguin PC; Levy P; Ribuot C; Godin-Ribuot D
    Fundam Clin Pharmacol; 2012 Aug; 26(4):454-62. PubMed ID: 21480981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat.
    Belaidi E; Beguin PC; Levy P; Ribuot C; Godin-Ribuot D
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H901-8. PubMed ID: 18083903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
    Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
    J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling.
    Xi L; Taher M; Yin C; Salloum F; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2369-75. PubMed ID: 15284066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic preconditioning facilitates acclimatization to hypobaric hypoxia in rat heart.
    Singh M; Shukla D; Thomas P; Saxena S; Bansal A
    J Pharm Pharmacol; 2010 Dec; 62(12):1729-39. PubMed ID: 21054399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
    Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
    Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.
    Cai Z; Manalo DJ; Wei G; Rodriguez ER; Fox-Talbot K; Lu H; Zweier JL; Semenza GL
    Circulation; 2003 Jul; 108(1):79-85. PubMed ID: 12796124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
    Ding HL; Zhu HF; Dong JW; Zhu WZ; Yang WW; Yang HT; Zhou ZN
    Acta Pharmacol Sin; 2005 Mar; 26(3):315-22. PubMed ID: 15715927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
    Patel HH; Hsu AK; Gross GJ
    Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
    Jiang X; Shi E; Nakajima Y; Sato S
    Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote renal preconditioning-induced cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases.
    Kant R; Diwan V; Jaggi AS; Singh N; Singh D
    Mol Cell Biochem; 2008 May; 312(1-2):25-31. PubMed ID: 18273560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
    Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
    Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation.
    Zhao H; Wang Y; Wu Y; Li X; Yang G; Ma X; Zhao R; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):745-53. PubMed ID: 19727523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
    He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
    Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning and post-treatment with cobalt chloride in rat model of perinatal hypoxic-ischemic encephalopathy.
    Dai Y; Li W; Zhong M; Chen J; Liu Y; Cheng Q; Li T
    Brain Dev; 2014 Mar; 36(3):228-40. PubMed ID: 23694759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of the right ventricle from ischemia and reperfusion by preceding hypoxia.
    Wasserfuhr D; Cetin SM; Yang J; Freitag P; Frede S; Jakob H; Massoudy P
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):27-32. PubMed ID: 18488199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and activation of hypoxia inducible factor-1alpha and iNOS in the brain of rats with chronic intermittent hypoxia].
    Wang ZF; Kang J; Dai B
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Oct; 32(10):739-43. PubMed ID: 20079239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.